Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk-Reference-Cited by-同舟云学术

Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk

Published:2023-07 Issue:7 Volume:11 Page:825-835
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Khan Muhammad Shahzeb,Segar Matthew W.,Usman Muhammad Shariq,Patel Kershaw V.,Van Spall Harriette G.C.^ORCID,DeVore Adam D.,Vaduganathan Muthiah,Lam Carolyn S.P.,Zannad Faiez^ORCID,Verma Subodh,Butler Javed,Tang W.H. Wilson,Pandey Ambarish

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends;Khan;J Epidemiol Glob Health,2020

2. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association;Joseph;Circulation,2022

3. Temporal trends in heart failure incidence among Medicare beneficiaries across risk factor strata, 2011 to 2016;Khera;Jama Netw Open,2020

4. Trends in hospitalizations for heart failure and ischemic heart disease among US adults with diabetes;Honigberg;JAMA Cardiol,2021

5. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes;Rawshani;N Engl J Med,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electronic Health Record Alert With Heart Failure Risk and Sodium Glucose Cotransporter 2 Inhibitor Prescriptions in Diabetes: A Randomized Clinical Trial;Journal of Diabetes Science and Technology;2024-09-10

2. Development and validation of a machine learning‐based approach to identify high‐risk diabetic cardiomyopathy phenotype;European Journal of Heart Failure;2024-09-06

3. Advancements in Incident Heart Failure Risk Prediction and Screening Tools;The American Journal of Cardiology;2024-09

4. A simple tool to screen for heart failure with preserved ejection fraction;Nature Medicine;2024-07-25

5. Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer;Texas Heart Institute Journal;2024-04-09